
Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a 9-item self-report instrument that measures depression severity over the last 2 weeks. It was validated by Kroenke et al. (2001) as the depression module of the Patient Health Questionnaire.
Table of Contents
Items and Structure of the PHQ-9
The PHQ-9 consists of 9 items that ask how often a person has been bothered by a depression symptom over the last 2 weeks, such as "Little interest or pleasure in doing things?" Each item is scored on a 4-point scale: 0 ("Not at all"), 1 ("Several days"), 2 ("More than half the days"), or 3 ("Nearly every day"). The development paper did not measure completion time (Kroenke et al., 2001).
A final question asks how difficult these problems have made it to work, take care of things at home, or get along with other people. It is not used in calculating any score and instead gives a global impression of symptom-related impairment (Pfizer, n.d.). Item 9 asks about thoughts of death or self-harm, so any study using the PHQ-9 should plan in advance how it will respond to positive answers. The manual states that a final decision about self-harm risk requires a clinical interview (Pfizer, n.d.).

This study measures depression symptom severity using the PHQ-9. Responses are automatically scored into a total score and severity category within Labvanced.
Click the card above to see the full item list and study structure on Labvanced. Use Inspect to view it directly, or Import to copy the study into your own account and customize it.
Scoring Summary
The 9 item scores are summed into a single total score ranging from 0 to 27, with higher scores indicating greater depression severity. There are no subscales or reverse-scored items.
For the full scoring procedure and severity interpretation, see the PHQ-9 Scoring and Interpretation guide.
Psychometric Properties of the PHQ-9
- Reliability: Cronbach's α was .89 in a primary care sample and .86 in an obstetrics-gynecology sample of 3,000 patients each. Scores from the clinic PHQ-9 and a telephone administration within 48 hours correlated at .84 (Kroenke et al., 2001).
- Validity: Against a mental health professional's interview in 580 primary care patients, a score of 10 or above had 88% sensitivity and 88% specificity for major depression (Kroenke et al., 2001). An individual participant data meta-analysis of 17,357 participants found that a cutoff of 10 or above maximized combined sensitivity and specificity, with sensitivity of .88 and specificity of .85 in studies using semistructured interviews (Levis et al., 2019).
- Normative Information: Severity bands (see the Scoring and Interpretation guide) come from the development paper. In a nationally representative German sample (n = 5,018), mean scores were 3.1 (SD = 3.5) for women and 2.7 (SD = 3.5) for men (Kocalevent et al., 2013).
Data Collected with the PHQ-9
The PHQ-9 captures item-level responses, a computed total score, and a severity category within Labvanced. All variables can be viewed and customized within the study's Variables Tab.
| Variable Name | Description |
|---|---|
Item 1 – Item 9 | Participant's raw selection for each symptom item, stored as 1 to 4 |
Item 1 score – Item 9 score | Item score from 0 to 3, the raw selection minus 1 |
Item 10 | Answer to the difficulty question, from 1 (Not difficult at all) to 4 (Extremely difficult), not included in the total |
PHQ-9 Items | Array combining the 9 item scores |
Total Score | Sum of the 9 item scores (range 0-27) |
Severity | Severity category based on the total score: Minimal, Mild, Moderate, Moderately severe, or Severe |

Technologies Supporting the PHQ-9
The PHQ-9 is a self-report instrument, but Labvanced allows additional data streams to be layered onto the study for deeper analysis beyond the item responses themselves.
- Automatic Scoring, No-Code Setup: Summation of the 9 item scores and assignment of the severity category are handled automatically within Labvanced's Questionnaire page structure, with no manual calculation required.
- Response Behavior via Mouse Tracking: Cursor movement toward and away from response options can reveal hesitation or indecision while a participant is completing a depression item, adding a behavioral layer beyond the selected answer itself.
- Webcam-Based Eye Tracking: Gaze patterns while reading and answering each item can be captured with built-in, code-free webcam eye tracking, useful for attention-check analysis or studying how participants engage with different symptom items.
- Audio and Video Recording: Sessions can be recorded alongside item responses, useful when a researcher wants a qualitative record of participant behavior during a depression assessment.
- Desktop App for Controlled Administration: For clinical or lab settings administering the PHQ-9 as part of a larger intake battery, the Labvanced desktop app supports standardized, offline-capable administration on dedicated in-lab machines.
Mouse Tracking
Capture cursor movement and response hesitation alongside standard questionnaire answers.
Webcam Eye Tracking
Capture gaze patterns and visual attention with built-in, code-free and peer-reviewed webcam eye-tracking.
Desktop App
Run in-lab, controlled administration using the Desktop App, ideal for clinical intake settings.
Administration Options for the PHQ-9
There are several ways this instrument can be configured in Labvanced.
- Standard Questionnaire Setup: As a fixed-item Likert scale, the PHQ-9 is built using a standard
Page Frame, where items are listed top to bottom. See the Questionnaires implementation guide for how Page Frames, question objects, and scoring are set up in Labvanced. - Repeated Administration: The PHQ-9 can be given at several timepoints to track change, as in treatment monitoring or a longitudinal study. Labvanced supports repeated, scheduled administration with automated participant reminders.
- Multi-Language Deployment: Translations of the PHQ-9 are freely downloadable from the PHQ website, although the manual notes that few have been psychometrically validated against an independent structured psychiatric interview (Pfizer, n.d.). Labvanced supports multi-lingual study deployment, allowing a translated version to be configured for the target population.
The card below covers the different ways researchers can build and analyze questionnaires in Labvanced. Beyond fixed Likert items, it supports image, video, and audio stimuli, drag-and-drop and slider-based interactions, branching logic and randomization, and real-time feedback. Layouts can be freely positioned on a canvas or auto-flowing in a page frame, and responses can be automatically scored, reverse-scored, and timed down to the individual item.
If there is something else you'd like to know, please feel welcome to write to us and ask:
Recommended Use and Applications of the PHQ-9
The PHQ-9 is used across clinical, population, and workplace research to measure depression symptoms.
- General population surveys: In nationally representative samples from the UK, Ireland, Spain, and Italy (combined N = 6,054), PHQ-9 scores were unidimensional, reliable, and largely free of differential item functioning by age, sex, and country (Shevlin et al., 2022).
- Occupational health research: In 955 Puerto Rican workers, the Spanish PHQ-9 was found to be reliable and valid, with a unidimensional reading of its scores judged the most parsimonious and results invariant across sex (Rosario-Hernández et al., 2023).
- Adolescent screening research: Evidence is mixed. In 2,235 Spanish secondary school students aged 12-18, scores fit a one-factor model with an omega of .87 (Fonseca-Pedrero et al., 2023), while among 2,237 Chinese children and adolescents who had screened positive on a self-administered questionnaire, the PHQ-9 performed poorly at detecting clinical depression (Wang et al., 2025).
- Treatment monitoring: In 434 older adults in a depression treatment trial, the PHQ-9 was responsive to treatment, with a minimal clinically important difference for individual change estimated at 5 points (Löwe et al., 2004).
Explore Related Cognitive Tasks
Stroop Test Effect
Measures attentional control and interference resolution through color-word conflict. A meta-analysis of 113 studies found major depressive disorder reliably associated with impaired performance on neuropsychological measures of executive function, with effect sizes from 0.32 to 0.97 (Snyder, 2013), the broader domain this task draws on.
Delay Discounting Task (DDT)
Measures how strongly people devalue rewards that arrive later. In a study of 82 participants, those with current major depression discounted large future rewards at a higher rate than remitted patients and healthy controls, which the authors linked to depressive symptoms, specifically hopelessness (Pulcu et al., 2014).

References
- Fonseca-Pedrero, E., Díez-Gómez, A., Pérez-Albéniz, A., Al-Halabí, S., Lucas-Molina, B., & Debbané, M. (2023). Youth screening depression: Validation of the Patient Health Questionnaire-9 (PHQ-9) in a representative sample of adolescents. Psychiatry Research, 328, 115486. https://doi.org/10.1016/j.psychres.2023.115486
- Kocalevent, R. D., Hinz, A., & Brähler, E. (2013). Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. General Hospital Psychiatry, 35(5), 551-555. https://doi.org/10.1016/j.genhosppsych.2013.04.006
- Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
- Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476
- Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Medical Care, 42(12), 1194-1201. https://doi.org/10.1097/00005650-200412000-00006
- Pfizer. (n.d.). Instruction manual: Instructions for Patient Health Questionnaire (PHQ) and GAD-7 measures. Retrieved November 4, 2026, from https://www.phqscreeners.com/images/sites/g/files/g10016261/f/201412/instructions.pdf
- Pulcu, E., Trotter, P. D., Thomas, E. J., McFarquhar, M., Juhasz, G., Sahakian, B. J., Deakin, J. F. W., Zahn, R., Anderson, I. M., & Elliott, R. (2014). Temporal discounting in major depressive disorder. Psychological Medicine, 44(9), 1825-1834. https://doi.org/10.1017/S0033291713002584
- Rosario-Hernández, E., Rovira-Millán, L. V., Merino-Soto, C., & Angulo-Ramos, M. (2023). Review of the psychometric properties of the Patient Health Questionnaire-9 (PHQ-9) Spanish version in a sample of Puerto Rican workers. Frontiers in Psychiatry, 14, 1024676. https://doi.org/10.3389/fpsyt.2023.1024676
- Shevlin, M., Butter, S., McBride, O., Murphy, J., Gibson-Miller, J., Hartman, T. K., Levita, L., Mason, L., Martinez, A. P., McKay, R., Stocks, T. V., Bennett, K. M., Hyland, P., Vallieres, F., Valiente, C., Vazquez, C., Contreras, A., Peinado, V., Trucharte, A., ... Bentall, R. P. (2022). Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic. BMC Psychiatry, 22(1), 154. https://doi.org/10.1186/s12888-022-03787-5
- Snyder, H. R. (2013). Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychological Bulletin, 139(1), 81-132. https://doi.org/10.1037/a0028727
- Wang, S., Lu, J., Zheng, G., He, Y., Liu, S., Xiang, Y., Liu, X., Wang, X., & Xiao, Y. (2025). Poor performance of PHQ-9 and GAD-7 in screening clinical depression and anxiety among a large sample of Chinese children and adolescents. BMC Psychiatry, 25(1), 301. https://doi.org/10.1186/s12888-025-06754-y